Adicet Bio, Inc. (ACET) stock

ACETNasdaqPharmaceutical PreparationsFiscal year ends December 26

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30

$2.93−0.06 (-2.01%)

Close on Nov 12, 2026Market cap $27.43MP/E –Yield –

Adicet Bio EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Adicet Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?